Cover Image
Market Research Report

Cataract Surgery Devices - Medical Devices Pipeline Assessment, 2018

Published by GlobalData Product code 227697
Published Content info 122 Pages
Immediate Delivery Available
Price
Back to Top
Cataract Surgery Devices - Medical Devices Pipeline Assessment, 2018
Published: May 1, 2018 Content info: 122 Pages
Description

GlobalData's Medical Devices sector report, "Cataract Surgery Devices - Medical Devices Pipeline Assessment, 2018" provides an overview of Cataract Surgery Devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Cataract Surgery Devices pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Cataract Surgery Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Cataract Surgery Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry.

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Cataract Surgery Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date
Table of Contents
Product Code: GDME0546EPD

Table of Contents

1 Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 6
  • 1.2 List of Figures 7

2 Introduction 9

  • 2.1 Cataract Surgery Devices Overview 9

3 Products under Development 10

  • 3.1 Cataract Surgery Devices - Pipeline Products by Stage of Development 10
  • 3.2 Cataract Surgery Devices - Pipeline Products by Segment 11
  • 3.3 Cataract Surgery Devices - Pipeline Products by Territory 12
  • 3.4 Cataract Surgery Devices - Pipeline Products by Regulatory Path 13
  • 3.5 Cataract Surgery Devices - Pipeline Products by Estimated Approval Date 14
  • 3.6 Cataract Surgery Devices - Ongoing Clinical Trials 15

4 Cataract Surgery Devices - Pipeline Products under Development by Companies 16

  • 4.1 Cataract Surgery Devices Companies - Pipeline Products by Stage of Development 16
  • 4.2 Cataract Surgery Devices - Pipeline Products by Stage of Development 17

5 Cataract Surgery Devices Companies and Product Overview 18

  • 5.1 Advanced Refractive Technologies Inc Company Overview 18
    • 5.1.1 Advanced Refractive Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 18
  • 5.2 Altacor Ltd Company Overview 20
    • 5.2.1 Altacor Ltd Pipeline Products & Ongoing Clinical Trials Overview 20
  • 5.3 Bausch & Lomb Inc Company Overview 21
    • 5.3.1 Bausch & Lomb Inc Pipeline Products & Ongoing Clinical Trials Overview 21
  • 5.4 Carl Zeiss Meditec AG Company Overview 29
    • 5.4.1 Carl Zeiss Meditec AG Pipeline Products & Ongoing Clinical Trials Overview 29
  • 5.5 Cirle, Inc Company Overview 30
    • 5.5.1 Cirle, Inc Pipeline Products & Ongoing Clinical Trials Overview 30
  • 5.6 Eye Care and Cure Company Overview 31
    • 5.6.1 Eye Care and Cure Pipeline Products & Ongoing Clinical Trials Overview 31
  • 5.7 International BioMedical Devices Inc Company Overview 32
    • 5.7.1 International BioMedical Devices Inc Pipeline Products & Ongoing Clinical Trials Overview 32
  • 5.8 Medicontur Medical Engineering Ltd Company Overview 33
    • 5.8.1 Medicontur Medical Engineering Ltd Pipeline Products & Ongoing Clinical Trials Overview 33
  • 5.9 Mynosys Cellular Devices, Inc. Company Overview 34
    • 5.9.1 Mynosys Cellular Devices, Inc. Pipeline Products & Ongoing Clinical Trials Overview 34
  • 5.10 OptoLight Vision Technology Company Overview 37
    • 5.10.1 OptoLight Vision Technology Pipeline Products & Ongoing Clinical Trials Overview 37
  • 5.11 Paradigm Medical Industries, Inc. (Inactive) Company Overview 40
    • 5.11.1 Paradigm Medical Industries, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 40
  • 5.12 Rhexis Biomedical Company Overview 41
    • 5.12.1 Rhexis Biomedical Pipeline Products & Ongoing Clinical Trials Overview 41
  • 5.13 Shanghai Haohai Biological Technology Co Ltd Company Overview 42
    • 5.13.1 Shanghai Haohai Biological Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 42
  • 5.14 STAAR Surgical Company Company Overview 43
    • 5.14.1 STAAR Surgical Company Pipeline Products & Ongoing Clinical Trials Overview 43
  • 5.15 Tear Diagno LLC (Inactive) Company Overview 44
    • 5.15.1 Tear Diagno LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 44
  • 5.16 University of Florida Company Overview 45
    • 5.16.1 University of Florida Pipeline Products & Ongoing Clinical Trials Overview 45
  • 5.17 University of Michigan Company Overview 46
    • 5.17.1 University of Michigan Pipeline Products & Ongoing Clinical Trials Overview 46
  • 5.18 University of Texas Medical Branch at Galveston Company Overview 47
    • 5.18.1 University of Texas Medical Branch at Galveston Pipeline Products & Ongoing Clinical Trials Overview 47
  • 5.19 VSY Biotechnology BV Company Overview 48
    • 5.19.1 VSY Biotechnology BV Pipeline Products & Ongoing Clinical Trials Overview 48
  • 5.20 Wake Forest Baptist Medical Center Company Overview 49
    • 5.20.1 Wake Forest Baptist Medical Center Pipeline Products & Ongoing Clinical Trials Overview 49

6 Cataract Surgery Devices- Recent Developments 50

  • 6.1 Apr 14, 2018: ZEISS presents diagnostic and surgical advancements at ASCRS 50
  • 6.2 Apr 13, 2018: LKC Technologies Partners with US Retina in GPO Program 51
  • 6.3 Apr 06, 2018: Cataract surgery may be safe for Ebola virus survivors, can help restore vision 51
  • 6.4 Mar 22, 2018: LIGHTMED Appoints Dennis Dowell as Director of Sales and Marketing for North America 51
  • 6.5 Mar 08, 2018: Ocular Therapeutix Reports Fourth Quarter and Year End 2017 Financial Results and Business Update 52
  • 6.6 Mar 06, 2018: Proveo 8 with digital imaging to be Featured in a Live Surgery Presentation at Frankfurt Retina Meeting 54
  • 6.7 Mar 05, 2018: Anika Therapeutics Names Joseph Darling as CEO and Director 54
  • 6.8 Mar 01, 2018: Luis Iglesias Promoted to Head of Santen EMEA 55
  • 6.9 Feb 28, 2018: Valeant Announces Fourth-Quarter And Full-Year 2017 Financial Results 55
  • 6.10 Feb 28, 2018: STAAR Surgical Reports Fourth Quarter and Full Year 2017 Results 59
  • 6.11 Feb 28, 2018: Glaukos Reports Fourth Quarter and Full Year 2017 Financial Results 61
  • 6.12 Feb 26, 2018: Lensar Names Richard L. Lindstrom As Board Director 62
  • 6.13 Feb 21, 2018: Anika Announces Fourth Quarter and Full Year 2017 Financial Results 62
  • 6.14 Feb 20, 2018: Santen Announces Appointment of New President 63
  • 6.15 Jan 25, 2018: Lohmann & Rauscher: Personnel Change in Executive Board of L&R 64
  • 6.16 Jan 16, 2018: HOYA Surgical Optics Opens New Global R&D Centre in Singapore to Address Global Burden of Cataract 65
  • 6.17 Jan 08, 2018: Bausch + Lomb Receives CE Mark From The European Commission For The Stellaris Elite Vision Enhancement System, Including The VITESSE Vitrectomy System 66

7 Appendix 119

  • 7.1 Methodology 119
  • 7.2 About GlobalData 122
  • 7.3 Contact Us 122
  • 7.4 Disclaimer 122

List of Tables

1.1 List of Tables

  • Table 1: Cataract Surgery Devices - Pipeline Products by Stage of Development 10
  • Table 2: Cataract Surgery Devices - Pipeline Products by Segment 11
  • Table 3: Cataract Surgery Devices - Pipeline Products by Territory 12
  • Table 4: Cataract Surgery Devices - Pipeline Products by Regulatory Path 13
  • Table 5: Cataract Surgery Devices - Pipeline Products by Estimated Approval Date 14
  • Table 6: Cataract Surgery Devices - Ongoing Clinical Trials 15
  • Table 7: Cataract Surgery Devices Companies - Pipeline Products by Stage of Development 16
  • Table 8: Cataract Surgery Devices - Pipeline Products by Stage of Development 17
  • Table 9: Advanced Refractive Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 18
  • Table 10: Accupulse Cataract Emulsifier - Product Status 18
  • Table 11: Accupulse Cataract Emulsifier - Product Description 18
  • Table 12: Lens Opacity Threshold System - Product Status 19
  • Table 13: Lens Opacity Threshold System - Product Description 19
  • Table 14: Altacor Ltd Pipeline Products & Ongoing Clinical Trials Overview 20
  • Table 15: SOLO - Product Status 20
  • Table 16: SOLO - Product Description 20
  • Table 17: Bausch & Lomb Inc Pipeline Products & Ongoing Clinical Trials Overview 21
  • Table 18: BLS - 001: Cataract - Product Status 21
  • Table 19: BLS - 001: Cataract - Product Description 22
  • Table 20: BLS - 002: Cataract - Product Status 22
  • Table 21: BLS - 002: Cataract - Product Description 22
  • Table 22: BLS - 003: Cataract - Product Status 22
  • Table 23: BLS - 003: Cataract - Product Description 23
  • Table 24: BLS - 004: Cataract - Product Status 23
  • Table 25: BLS - 004: Cataract - Product Description 23
  • Table 26: BLS - 006: Cataract - Product Status 23
  • Table 27: BLS - 006: Cataract - Product Description 24
  • Table 28: BLS - 007: Cataract - Product Status 24
  • Table 29: BLS - 007: Cataract - Product Description 24
  • Table 30: BLS - 008: Cataract - Product Status 24
  • Table 31: BLS - 008: Cataract - Product Description 25
  • Table 32: BLS - 010: Cataract - Product Status 25
  • Table 33: BLS - 010: Cataract - Product Description 25
  • Table 34: BLS - 011: Cataract - Product Status 25
  • Table 35: BLS - 011: Cataract - Product Description 26
  • Table 36: BLS - 015: Cataract - Product Status 26
  • Table 37: BLS - 015: Cataract - Product Description 26
  • Table 38: BLS - 016: Cataract - Product Status 26
  • Table 39: BLS - 016: Cataract - Product Description 27
  • Table 40: Cirle 3-D Surgical Navigation System - Product Status 27
  • Table 41: Cirle 3-D Surgical Navigation System - Product Description 27
  • Table 42: Ophthalmic Viscosurgical Device - Product Status 27
  • Table 43: Ophthalmic Viscosurgical Device - Product Description 28
  • Table 44: Carl Zeiss Meditec AG Pipeline Products & Ongoing Clinical Trials Overview 29
  • Table 45: VisuMax Femtosecond Laser - Astigmatic Myopia - Product Status 29
  • Table 46: VisuMax Femtosecond Laser - Astigmatic Myopia - Product Description 29
  • Table 47: Cirle, Inc Pipeline Products & Ongoing Clinical Trials Overview 30
  • Table 48: SNS 200 - Product Status 30
  • Table 49: SNS 200 - Product Description 30
  • Table 50: Eye Care and Cure Pipeline Products & Ongoing Clinical Trials Overview 31
  • Table 51: Ophthalmic Device - Cataract Surgery - Product Status 31
  • Table 52: Ophthalmic Device - Cataract Surgery - Product Description 31
  • Table 53: International BioMedical Devices Inc Pipeline Products & Ongoing Clinical Trials Overview 32
  • Table 54: ApertureRx Precision Capsulotomy System - Product Status 32
  • Table 55: ApertureRx Precision Capsulotomy System - Product Description 32
  • Table 56: Medicontur Medical Engineering Ltd Pipeline Products & Ongoing Clinical Trials Overview 33
  • Table 57: Pre-Filled Injection System - Product Status 33
  • Table 58: Pre-Filled Injection System - Product Description 33
  • Table 59: Mynosys Cellular Devices, Inc. Pipeline Products & Ongoing Clinical Trials Overview 34
  • Table 60: ZEPTO - Product Status 34
  • Table 61: ZEPTO - Product Description 34
  • Table 62: Mynosys Cellular Devices, Inc. - Ongoing Clinical Trials Overview 35
  • Table 63: ZEPTO - A Prospective Multi-Center Study of Anterior Lens Capsulotomy Using the Mynosys Zepto System 36
  • Table 64: OptoLight Vision Technology Pipeline Products & Ongoing Clinical Trials Overview 37
  • Table 65: Lipshitz Macular Implant - Diabetic Maculopathy - Product Status 37
  • Table 66: Lipshitz Macular Implant - Diabetic Maculopathy - Product Description 37
  • Table 67: OptoLight Vision Technology - Ongoing Clinical Trials Overview 38
  • Table 68: Lipshitz Macular Implant - Diabetic Maculopathy - Efficacy of the Telescopic Mirror Implant for Age-related Macular Degeneration: The MIRROR Trial 39
  • Table 69: Paradigm Medical Industries, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 40
  • Table 70: Photon Laser System - Product Status 40
  • Table 71: Photon Laser System - Product Description 40
  • Table 72: Rhexis Biomedical Pipeline Products & Ongoing Clinical Trials Overview 41
  • Table 73: Rhexis Biomedical Surgical Instrument - Product Status 41
  • Table 74: Rhexis Biomedical Surgical Instrument - Product Description 41
  • Table 75: Shanghai Haohai Biological Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 42
  • Table 76: QST Gel - OVD - Product Status 42
  • Table 77: QST Gel - OVD - Product Description 42
  • Table 78: STAAR Surgical Company Pipeline Products & Ongoing Clinical Trials Overview 43
  • Table 79: Preloaded Injector System - Collamer IOL - Product Status 43
  • Table 80: Preloaded Injector System - Collamer IOL - Product Description 43
  • Table 81: Tear Diagno LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 44
  • Table 82: Cataract Surgical Device - Product Status 44
  • Table 83: Cataract Surgical Device - Product Description 44
  • Table 84: University of Florida Pipeline Products & Ongoing Clinical Trials Overview 45
  • Table 85: Tool For Intraocular Lens Removal - Product Status 45
  • Table 86: Tool For Intraocular Lens Removal - Product Description 45
  • Table 87: University of Michigan Pipeline Products & Ongoing Clinical Trials Overview 46
  • Table 88: Surgical Knife - Product Status 46
  • Table 89: Surgical Knife - Product Description 46
  • Table 90: University of Texas Medical Branch at Galveston Pipeline Products & Ongoing Clinical Trials Overview 47
  • Table 91: Ocular Surgery Device - Product Status 47
  • Table 92: Ocular Surgery Device - Product Description 47
  • Table 93: VSY Biotechnology BV Pipeline Products & Ongoing Clinical Trials Overview 48
  • Table 94: Protectolan 3% - Product Status 48
  • Table 95: Protectolan 3% - Product Description 48
  • Table 96: Wake Forest Baptist Medical Center Pipeline Products & Ongoing Clinical Trials Overview 49
  • Table 97: Aspiration And Irrigation Handpiece Tip - Product Status 49
  • Table 98: Aspiration And Irrigation Handpiece Tip - Product Description 49
  • Table 99: Glossary 121

List of Figures

1.2 List of Figures

  • Figure 1: Cataract Surgery Devices - Pipeline Products by Stage of Development 10
  • Figure 2: Cataract Surgery Devices - Pipeline Products by Segment 11
  • Figure 3: Cataract Surgery Devices - Pipeline Products by Territory 12
  • Figure 4: Cataract Surgery Devices - Pipeline Products by Regulatory Path 13
  • Figure 5: Cataract Surgery Devices - Pipeline Products by Estimated Approval Date 14
  • Figure 6: Cataract Surgery Devices - Ongoing Clinical Trials 15
Back to Top